Pathology re-review
Independent Pathology Re-Review
Have your biopsy slides re-read by a subspecialty cancer pathologist. The single most common reason a second opinion changes a treatment plan.
Slides re-read by pathologists who focus on a single organ system — breast, GI, hematopathology, GU, dermatopathology.
We obtain your original slides; the re-read happens on the same tissue your first pathologist saw, plus any additional staining needed.
Pathology re-review can be requested on its own or bundled with imaging and multidisciplinary consultation.
Why this kind of review matters
Roughly 10–15% of cancer second opinions involve a meaningful change to the pathologic diagnosis or grade. The number is even higher for rare tumors, lymphomas, sarcomas, and ambiguous biopsies.
Pathology is fundamentally pattern recognition. A subspecialty pathologist who has personally signed out hundreds of cases of your specific tumor sees details a generalist may not flag.
Changing the diagnosis or grade often changes everything downstream — whether chemotherapy is needed, which regimen, the role of radiation, and surgical extent.
What's included
Slide retrieval
We coordinate release of your slides and block from the original pathology lab using a single signed authorization.
Subspecialty re-read
Slides reviewed by a pathologist who subspecializes in your tumor type.
Additional staining if needed
Immunohistochemistry, molecular testing, or FISH ordered when the re-read suggests it would change interpretation.
Written pathology report
A formal addendum report sent to you and (with permission) your oncologist and original pathologist.
Consultation visit (optional)
A 30-minute video visit with the oncology team to walk through what the re-read means for treatment.
How it works
- 1
Request the re-review
Tell us your diagnosis and the lab where the biopsy was performed.
- 2
Slides obtained
We send the release; the original lab ships slides directly to our pathology team.
- 3
Subspecialty re-read
Typically completed within 5–10 business days. Additional staining adds 1–2 weeks.
- 4
Report delivered
A formal addendum is sent to you. With permission, copies go to your oncologist and the original pathologist.
- 5
Optional consultation
If the re-read changes anything, a brief oncology consultation helps translate it into a plan.
- Patients with rare tumors (sarcoma, neuroendocrine, rare lymphomas)
- Patients with ambiguous or borderline biopsy findings
- Patients whose pathology doesn't match the clinical picture
- Patients facing high-stakes decisions where the diagnosis must be airtight
Frequently asked questions
Can I get a re-review without becoming a patient?
Yes. Pathology re-review can be requested as a standalone service. You don't need to transfer care or commit to a consultation.
How often does a re-read actually change the diagnosis?
Around 10–15% overall, higher for rare tumors and lymphomas. Even when the diagnosis stays the same, the re-read often refines the grade, subtype, or molecular profile in ways that affect treatment.
Will my original pathologist be offended?
No. Pathology re-reviews are routine in academic medicine and viewed as collaboration, not criticism. Most pathologists are glad to have complex cases reviewed by a subspecialist.
Does insurance cover the re-review?
Most PPO and Medicare plans cover pathology re-reviews as part of a second opinion. We verify coverage before the slides are pulled.
Request this review
Submit the form and a care coordinator will reach out within one business day.